We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$5.74B
AUM Growth
+$541M
(+10%)
Cap. Flow
+$368M
Cap. Flow
% of AUM
6.41%
Top 10 Holdings %
Top 10 Hldgs %
14.68%
Holding
2,530
New
949
Increased
622
Reduced
470
Closed
486
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$203M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$91.1M |
| 3 |
PG&E
PCG
|
+$57.7M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$53.7M |
| 5 |
Boston Scientific
BSX
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$67M |
| 2 |
iShares MSCI India ETF
INDA
|
+$55.1M |
| 3 |
Apple
AAPL
|
+$50.9M |
| 4 |
Intuit
INTU
|
+$43.3M |
| 5 |
Lowe's Companies
LOW
|
+$41.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.3% |
| 2 | Technology | 11.38% |
| 3 | Healthcare | 10.73% |
| 4 | Industrials | 10.27% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADMS
951
DELISTED
Adamas Pharmaceuticals
ADMS
| $774K | 0.01% |
22,828
+11,532
| +102% | +$322K |
|
|
JUNO
952
DELISTED
Juno Therapeutics, Inc.
JUNO
| $771K | 0.01% |
16,859
-100,324
| -86% | -$5M |
|
|
CIVI
953
DELISTED
Civitas Resources
CIVI
| $767K | 0.01% |
+27,811
| New | +$872K |
|
|
EPAY
954
DELISTED
Bottomline Technologies Inc
EPAY
| $766K | 0.01% |
22,088
+8,061
| +57% | +$270K |
|
955
Service Corp International
SCI
$11.4B
| $765K | 0.01% |
20,493
+12,958
| +172% | +$464K |
|
956
Tronox
TROX
$995M
| $763K | 0.01% |
+37,205
| New | +$907K |
|
957
Genworth Financial
GNW
$3.8B
| $762K | 0.01% |
245,042
+228,507
| +1,382% | +$790K |
|
|
MRC
958
DELISTED
MRC Global
MRC
| $757K | 0.01% |
44,713
+24,797
| +125% | +$410K |
|
959
AGNC Investment
AGNC
$12.3B
| $754K | 0.01% |
37,323
+20,319
| +119% | +$418K |
|
960
Invitation Homes
INVH
$17.7B
| $754K | 0.01% |
+31,987
| New | +$740K |
|
|
AIMT
961
DELISTED
Aimmune Therapeutics
AIMT
| $752K | 0.01% |
+19,891
| New | +$642K |
|
962
Red Robin
RRGB
$134M
| $748K | 0.01% |
+13,263
| New | +$763K |
|
963
Dillards
DDS
$8.87B
| $745K | 0.01% |
12,413
-37,880
| -75% | -$2.1M |
|
964
Gray Television
GTN
$407M
| $743K | 0.01% |
+44,329
| New | +$693K |
|
|
JBGS
965
JBG SMITH
JBGS
$846M
| $741K | 0.01% |
+21,343
| New | +$705K |
|
966
Nuveen California Quality Municipal Income Fund
NAC
$1.83B
| $741K | 0.01% |
+51,775
| New | +$757K |
|
967
Petrobras Class A
PBR.A
$107B
| $741K | 0.01% |
75,420
-97,380
| -56% | -$959K |
|
968
KBR
KBR
$4.68B
| $740K | 0.01% |
37,335
+1,671
| +5% | +$31.6K |
|
969
Hilltop Holdings
HTH
$2.29B
| $738K | 0.01% |
+29,118
| New | +$714K |
|
970
Fidelity National Information Services
FIS
$21.5B
| $737K | 0.01% |
+7,832
| New | +$736K |
|
971
Forestar Group
FOR
$1.44B
| $737K | 0.01% |
+33,504
| New | +$651K |
|
|
CNSL
972
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $736K | 0.01% |
60,394
+4,355
| +8% | +$68.4K |
|
|
MCRN
973
DELISTED
Milacron Holdings Corp.
MCRN
| $735K | 0.01% |
+38,416
| New | +$686K |
|
974
PIMCO Corporate & Income Opportunity Fund
PTY
$2.48B
| $733K | 0.01% |
+44,519
| New | +$741K |
|
|
TUP
975
DELISTED
Tupperware Brands Corporation
TUP
| $733K | 0.01% |
+11,690
| New | +$716K |
|
Similar funds
Squarepoint's Q4 2017 Portfolio in Review
As of Q4 2017, Squarepoint held 2,530 positions worth $5.74B, up 10% from $5.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Squarepoint deployed $368M of net new capital in Q4 2017, opening 949 new positions and adding to 622 existing holdings. Its largest new stake was Boston Scientific: 1,494,796 shares worth $37.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $50.9M trimmed.
- Squarepoint's largest Q4 2017 buy was Boston Scientific: 1,494,796 shares worth $37.1M.
- Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q4 2017, an estimated $203M increase.
- Squarepoint's biggest Q4 2017 reduction was Apple, cutting an estimated $50.9M.
- Squarepoint fully exited iShares MSCI Japan ETF in Q4 2017, selling an estimated $67M.
- Squarepoint's ten largest holdings make up 15% of its $5.74B portfolio in Q4 2017.
- Squarepoint opened 949 new positions and closed 486 in Q4 2017.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $5.74B.
Based on Squarepoint's 13F filing for Q4 2017, filed 14 Feb 2018.